middle.news

Paradigm Expands Global Knee OA Trial with New Sites and Strong Funding

9:23am on Friday 30th of January, 2026 AEDT • Healthcare
Read Story

Paradigm Expands Global Knee OA Trial with New Sites and Strong Funding

9:23am on Friday 30th of January, 2026 AEDT
Key Points
  • Majority of clinical sites active and recruiting in Australia and US
  • New international sites in Hong Kong and Moldova to start screening
  • Interim analysis on track for mid-2026 with 50% recruitment milestone
  • Phase 2 biomarker study published in leading peer-reviewed journal
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about PARADIGM BIOPHARMACEUTICALS LIMITED.. (ASX:PAR)
OPEN ARTICLE